Evidence map›Paper›PMID 42485184›Full record

ArticleSTAR protocols2026

A 3D RNA-protein proximity ligation protocol detecting the heterogeneity of LISRR-RPL26 interactions in patient-derived melanoma tumor explants.

Alessandro Marino, Eleonora Leucci

Abstract read
In one paragraph

Article in STAR protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alessandro MarinoLaboratory for RNA Cancer Biology, Department of Oncology, LKI, KU Leuven, 3000 Leuven, Belgium.
Eleonora LeucciLaboratory for RNA Cancer Biology, Department of Oncology, LKI, KU Leuven, 3000 Leuven, Belgium; TRACE, Laboratory for RNA Cancer Biology, Department of Oncology, LKI Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium. Electronic address: eleonora.leucci@kuleuven.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Investigating lncRNA-protein interactors is crucial for understanding their contribution to tumor formation and progression. Here, we present a protocol to explore the heterogeneity of RNA-protein interactions between the lncRNA LISRR and RPL26 ex vivo in 3D clinically relevant patient-derived melanoma models. We describe steps for sample preparation, RNA probe hybridization, and a proximity ligation assay. We then detail procedures for detection and analysis. This protocol bypasses tissue embedding and sectioning, significantly accelerating data acquisition.

Indexed as

AntibodyCancerCell-based AssaysIn Situ HybridizationMolecular/Chemical Probes

Identifiers

PMID42485184
PMCPMC13425803

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.